A META-ANALYSIS ASSESSING THE EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS ON SURROGATE ENDPOINTS IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION